"It has thus become increasingly important that the teaching of good medical research methods be expanded to scientists and institutions in low and middle-income countries that face major health challenges in the decades ahead. There is a critical shortage of technical skills in these countries and, for that matter, in
first-world nations researchers who are imbued with a deep understanding of the fundamental ideas underlying the successful design and analysis of medical and public health research studies. Such ideas must necessarily incorporate the latest algorithms and statistical approaches afforded by the computing and communication revolutions, in addition to the essential ethics of experimentation, policy advising and reporting to our communities regarding the public’s health."
Nicholas P. JEWELL, Ph.D., MedicReS Scientific Board Member
Good Medical Research is research that has the potential to deliver results that can improve the capabilities and decision-making of clinicians, and that obtains its results via methods that respect the rights of human subjects. Settling questions about what counts as good medical research is an interdisciplinary enterprise, requiring contributions from statisticians, scientists, clinicians, and ethicists, and the MedicReS is bringing these experts together. It is my hope that attendees will come away with a better understanding of the ethics of these trials. There is a growing consensus that clinical researchers are justified in doing less than their best for the subjects in their trials when necessary to obtain results that will help future patients more. I criticize this view on the grounds that it neglects the moral constraint against allowing harm as a means, and describe several trial designs that intend the harmful consequences of withholding care as a means to various research-related ends. I hope you will consider participating in MedicReS to hear a variety of presentations on the theme of good medical research, and to participate in the conversations they generate.
This is a great opportunity to get together and brainstorm and ponders about the
future of collaborative research.
Dr. Collin O’Neil - Lehman College, City University of New York.
MedicReS brings together a diverse group of researchers with differing experience and opinions. This is a great opportunity to get together and brainstorm and ponders about the future of collaborative research. My subject will discuss where analysis, particularly that of big data, is headed. My subject will discuss where analysis, particularly that of big data, is headed. I will discuss the definition of big data from a biostatistics perspective. It will review some of the work that has been done and where statistical analyses are headed in the future. Please join MedicReS Club as it is a great opportunity to discuss how to advance science using good, biostatistical, and ethical practices.
Dr. Denise A. Esserman,
Yale School of Public Health, Yale University,
The job of medical researchers is to ensure that these probabilities and uncertainty margins are robust—a task that is contingent on the pursuit, not of truth, but of methodological rigour. MedicReS aims to educate researchers and provoke discussion about good scientific method, statistics, ethics, publication, and education. Faced with stifling bureaucracy, competition for funds, and employer pressure to deliver results, finding the time and space to produce the best research can seem an arduous process. MedicReS should help to emancipate researchers, refocusing them on the steps to ensure that their research is as rigourous as possible.
EDITORIAL| VOLUME 379, ISSUE 9832, P2118, JUNE 09, 2012
Arzu Kanik, Prof.Dr. Ph.D., Scientific Director, MedicReS New York * Alvaro Atallah Md, Msc, Internal Medicine & Evidence-Based Medicine, Universidade Federal De São Paulo, Brasil * Brahmajee Nallamothu Md, Associate Professor, Division of Cardiovascular Diseases, Department of Internal Medicine Investigator, Center for the Clinical Management Research University of Michigan * Christiane Druml Ph.D. Vice-Rector for the Clinical Affairs Medical University of Vienna * David Madigan Executive Vice President for Arts and Science and Professor of Statistics at Columbia University in New York City * David Moher Associate Professor, School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa * Delia Wolf Regulatory Affairs & Research Compliance at Harvard School of Public Health, Boston * Denise Esserman Ph.D., Associate Professor of Public Health (Biostatistics), School of Public, Health: Yale Center for Analytical Sciences (Ycas) * Doug Altman Dsc. Director, Centre for Statistics in Medicine, University of Oxford * Fikret İkiz Emeritus Professor, Department of Biostatistics & Bioinformatics, Ege University * Gui- Shuang Ying Md, Ph.D., University of Pennsylvania, School of Medicine, Clinical Trial Coordinating Center, Department of Ophthalmology, Philadelphia, USA * Han Liu Assistant Professor, Department of Operations Research and Financial Engineering Princeton University * Hans Karle Md, Dmsc, Dhc, Frcp, Herlev University Hospital, University of Copenhagen * Iain Hrynaszkiewicz Biomed Central, London, United Kingdom * Iveta Simera Ph.D., Head of Programme Development, Equator Network, Centre for Statistics in Medicine, Oxford UK * Ivonne Solis-Trapala Ph.D., Mrc Fellow in Biostatistics, School of Health and Medicine, Lancaster, United Kingdom * Prof. Jonas Ranstam, Phd, Department of Clinical Sciences, Sweden * Francesca Martinelli, European Organization for Research Treatment of Cancer, Italy * John Overbeke Md, Phd, Representative MedicReS , Past President World Association of Medical Editors, Wame, Netherland * Judith D. Goldberg Professor of Biostatistics at New York University School of Medicine * Liz Wager Phd, Chair of Committee On Publication Ethics (Cope),United Kingdom * Marusic Ana Md, Phd, Chair of The Department of Research in Biomedicine and Health, University of Split School of Medicine, Croatia * Michael Berkowitz Md,Professor of Modern Jewish History ,Dept of Hebrew&Jewish Studies ,Faculty of Arts&Humanities ,London,UK * Michael Festing Phd, Biostatistics ,Cstat, London, UK * Dr. Justine Davies, Executive Editor Lancet, UK * Michael Schemper Phd, Medical University of Vienna, Core Unit of Medical Statistics and informatics, Section of Clinical Biometrics, Vienna, Austria * Monica Gaidhane Md, Mph, Clinical Research Manager at Weill Cornell Medical,Newyork,USA * Shelley Hurwitz Director of Biostatistics in The Center for Clinical investigation at Brigham and Women's Hospital, A Teaching Hospital of Harvard Medical School,Harvard Catalyst, Boston * Shing Lee Phd, Assistant Professor, Biostatistics at The Columbia University Medical Center,New York * Siegfried Kasper Md, Phd, Professor and Chairman, Department of Biological Psychiatry, Medical University of Vienna, Austria * Suzanne Pozsonyi Clinical Research Specialist, Syncon international Clinical Research, Consultancy , Hungary * Trish Groves Deputy Editor,BMJ Publishing Group,Medicine,London * Z. Nazan Alparslan Phd,University of Cukurova, Medical Faculty, Department of Biostatistics .